NHS England

Market Access

Matt Hancock has big shoes to fill as he takes over from Jer...

What changes will the appointment of Matt Hancock MP as Secretary of State for Health and Social Care mean for the NHS?

News

Fury as NHS rejects cystic fibrosis drug price offer

It may be the 70th birthday of the NHS but this was no day of celebration for a group of patients with cystic fibrosis who have been told by officials there is no way forward in a pricing r

News

Lung cancer drug Keytruda to become routinely available on N...

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.

Views & Analysis

NHS England takes charge on market access

Today sees patients gain full NHS access to breast cancer drug Perjeta, a full six years on from its initial review by NICE.

Views & Analysis

Broken injection syringe containing uk banknotes over a white background

UK pharma in 2017: NHS funding, a legal challenge and Brexit

The UK pharma industry added its voice to calls for greater NHS funding in 2017 – but Brexit guaranteed there could be no rescue package

News

Pharma welcomes NHS drive to cut clinical trials red tape

The NHS is doing its bit to make England a more attractive place to develop drugs, with a new plan to cut costs and improve data and technology support for clinical trials.

Matt Hancock has big shoes to fill as he takes over from Jer...

Fury as NHS rejects cystic fibrosis drug price offer

Lung cancer drug Keytruda to become routinely available on N...

NHS England takes charge on market access

UK pharma in 2017: NHS funding, a legal challenge and Brexit

Pharma welcomes NHS drive to cut clinical trials red tape

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

NHS England

Editor's Picks